Low-Dose Hormonal Contraceptives Do Not Increase Metabolic Syndrome Risk in Obese Women With PCOS: COMET-PCOS Trial
USA: Researchers have reported that low-dose combined hormonal contraceptives (CHCs) can effectively control symptoms of polycystic ovary syndrome (PCOS) without increasing the burden of metabolic syndrome in women with hyperandrogenic…